Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
Related Posts
Alibaba launches new open-source AI model for ‘cost-effective AI agents’
Alibaba Cloud has launched its latest AI model in its “Qwen series,” as large language model competition in China continues to heat up.
Apple turns its AI on by default in latest software update
Apple released a software update for iPhones, iPads and Macs that turns Apple Intelligence on by default for users with supported devices.
LA wildfires thrust insurance startup into spotlight as property owners scramble for protection
A month after announcing its first funding round and debut insurance product, Stand is seeing a huge surge in interest due to the LA wildfires.